72
1
5
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T16136 |
MRS-1706
|
Adenosine Receptor | GPCR/G Protein; Neuroscience |
MRS-1706 是一种选择性A2B 腺苷受体的反向激动剂,对人 A2B、A2A、A1和 A3受体的Ki 值分别为 1.39、112、157 和 230 nM。 | |||
T6172 |
MRS 2578
|
Apoptosis; P2Y Receptor | Apoptosis; GPCR/G Protein; Neuroscience |
MRS 2578 是一种选择性强的P2Y6 受体拮抗剂,IC50为 37 nM,对 P2Y1、P2Y2、P2Y4 和 P2Y11 受体显示出不显着的抑制作用。 | |||
T16140 |
MRS 1754
|
Adenosine Receptor | GPCR/G Protein; Neuroscience |
MRS 1754 是A2B 腺苷受体选择性拮抗剂,对人和大鼠的 A1和 A3受体的亲和力非常低。 | |||
T12107 |
MRS-3777 hemioxalate
|
Adenosine Receptor | GPCR/G Protein; Neuroscience |
MRS-3777 hemioxalate 是一种选择性腺苷 A3 受体拮抗剂,可逆转其相应激动剂的抗伤害感受作用,可用于研究炎症性疼痛。 | |||
T23016 |
MRS1220
MRS 1220 |
Adenosine Receptor | GPCR/G Protein; Neuroscience |
MRS1220 是一种高效、选择性的人 A3 腺苷受体 (hA3AR) 拮抗剂,Ki 为 0.59 nM,可用于中枢神经系统疾病的研究。MRS1220 在体内还减少了胶质母细胞瘤的肿瘤大小和血管形成。 | |||
T28096 |
MRS 4062 triethylammonium salt
MRS-4062,MRS4062,MRS 4062 |
||
MRS 4062 triethylammonium salt is a selective P2Y4 receptor agonist (EC50 values are 23, 640, and 740 nM for hP2Y4, hP2Y2 and hP2Y6 respectively). | |||
T37129 |
MRS 2905
|
||
Potent and selective P2Y14 receptor agonist (EC50 = 0.92 nM). Exhibits >2000-fold selectivity over P2Y6. Das et al (2010) Human P2Y14 receptor agonists: truncation of the hexose moiety of uridine-5'-diphosphoglucose and its replacement with alkyl and aryl groups J.Med.Chem. 53 471 PMID:19902968 |Lazarowski et al (2015) UDP-sugars as extracellular signaling molecules: cellular and physiologic consequences of P2Y14 receptor activation. Mol.Pharmacol. 88 151 PMID:25829059 | |||
T23020 |
MRS 2219
|
Others | Others |
P2X1 receptor potentiator | |||
T69255 |
MRS-2339
|
||
MRS-2339 is a P2X receptor activator. | |||
T16135 |
MRS 1523
|
Others | Others |
MRS 1523 can exert an antihyperalgesic effect through N-type Ca channel block and action potential inhibition in isolated rat dorsal root ganglion (DRG) neurons. MRS 1523 is an effective and selective adenosine A3 receptor antagonist Ki: 18.9 nM and 113 n | |||
T23019 |
MRS 2211
|
Others | Others |
P2Y13 receptor antagonist | |||
T23017 |
MRS 1334
|
Others | Others |
antagonist for the human adenosine A3 receptor | |||
T23024 |
MRS 2690
|
Others | Others |
P2Y14 receptor agonist | |||
T16134 |
MRS-1191
|
Others | Others |
MRS-1191 is an effective and selective A3 adenosine receptor antagonist (KB: 92 nM, a Ki: 31.4 nM for human A3 receptor and an IC50: 120 nM for CHO cells). | |||
T23022 |
MRS 2365
|
Others | Others |
Highly potent, selective P2Y1 receptor agonist | |||
T25837 |
MRS-1477
|
||
MRS-1477 is used as a TRPV1 positive allosteric modulator (PAM). | |||
T23026 |
MRS 2768 tetrasodium salt
|
Others | Others |
MRS 2768 tetrasodium salt is a P2Y2 agonist. | |||
T23025 |
MRS 2693 trisodium salt
|
Others | Others |
MRS 2693 trisodium salt is a P2Y6 agonist. | |||
T12108 |
MRS1845
|
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
MRS1845 is a selective inhibitor of store-operated calcium (SOC) channel (IC50 of 1.7 μM). | |||
TP2271 |
MRS 2957 triethylammonium salt
|
Others | Others |
MRS 2957 triethylammonium salt is a P2Y6 agonist. | |||
T33507 |
MRS923
MRS 923,MRS-923 |
||
MRS923 is a bioactive chemical. | |||
T33504 |
MRS1486
MRS 1486,MRS-1486 |
||
MRS1486 is a bioactive chemical. | |||
T33502 |
MRS1132
MRS 1132,MRS-1132 |
||
MRS1132 is a bioactive chemical. | |||
T28106 |
MRS5698
MRS 5698,MRS-5698 |
||
MRS5698 is a high affinity and selective agonist of A3 adenosine receptor (Ki ~ 3 nM) protects against chronic neuropathic pain. MRS5698 displays >1000-fold selectivity over A1 and A2A adenosine receptors | |||
T33496 |
MRS1062
MRS-1062,MRS 1062 |
||
MRS1062 is a bioactive chemical. | |||
T28097 |
MRS1067
MRS 1067,MRS-1067 |
||
MRS1067 is an antagonist of A3 adenosine receptor. | |||
T28101 |
MRS2496
MRS 2496,MRS-2496 |
||
MRS2496 is a P2Y(1) receptor antagonist. | |||
T33500 |
MRS1086
MRS-1086,MRS 1086 |
||
MRS1086 is a bioactive chemical. | |||
T33499 |
MRS1084
MRS 1084,MRS-1084 |
||
MRS1084 is a bioactive chemical. | |||
T33495 |
MRS1042
MRS-1042,MRS 1042 |
||
MRS1042 is a bioactive chemical. | |||
T33498 |
MRS1066
MRS 1066,MRS-1066 |
||
MRS1066 is a bioactive chemical. | |||
T28098 |
MRS1097
MRS-1097,MRS 1097 |
||
MRS1097 is a selective antagonist A3 adenosine receptor. | |||
T24499 |
MRS4478
MRS-4478,MRS 4478 |
||
MRS4478 is an effective inhibitor of the P2Y14 Receptor. | |||
T33505 |
MRS1505
MRS-1505,MRS 1505 |
||
MRS1505 is a bioactive chemical. | |||
T28099 |
MRS2179
MRS 2179,MRS-2179 |
||
MRS2179 is a competitive P2Y1 receptor antagonist (Kb = 100 nM) with no appreciable activity at P2Y2, P2Y4, or P2Y6 at concentrations up to 30 µM, or at P2Y12 and P2Y13. It inhibits ADP-induced platelet shape change and aggregation (pA2 = 6.55) in vitro a | |||
T33497 |
MRS1065
MRS 1065,MRS-1065 |
||
MRS1065 is a bioactive chemical. | |||
T28105 |
MRS3558
MRS-3558,MRS 3558 |
||
MRS3558 is an agonist of A3 adenosine receptors. | |||
T33503 |
MRS1476
MRS-1476,MRS 1476 |
||
MRS1476 is a bioactive chemical. | |||
T24498 |
MRS4458
MRS 4458,MRS-4458 |
||
MRS4458 is an effective inhibitor of the P2Y14 Receptor. | |||
T23021 |
MRS2279
MRS 2279 |
Others | Others |
Selective, high affinity competitive antagonist of the P2Y1 receptor | |||
T33501 |
MRS1093
MRS-1093,MRS 1093 |
||
MRS1093 is a bioactive chemical. | |||
T28100 |
MRS2298
MRS-2298,MRS 2298 |
||
MRS2298, a potent antagonists of the P2Y 1 receptor, has antiaggregatory activity in human platelets. | |||
T28103 |
MRS2603
MRS-2603,MRS 2603 |
||
MRS2603 is an antagonist of P2Y1 and P2Y13 receptors in 1321N1 human astrocytoma cells. | |||
T33506 |
MRS2220
MRS 2220,MRS-2220 |
||
MRS2220 is a selective enhancer of the ATP effects at fast desensitizing P2X (P2X1 and P2X3) receptors. | |||
T28102 |
MRS2567
MRS-2567,MRS 2567 |
||
MRS2567 is a potent P2Y6 nucleotide receptors antagonists. | |||
T33494 |
MRS1041
MRS-1041,MRS 1041 |
||
MRS1041 is a bioactive chemical. | |||
T24497 |
MRS2500
MRS-2500,MRS 2500 |
||
MRS2500 is a highly potent and selective platelet P2Y1 receptor antagonist. | |||
T28104 |
MRS2802
GTPL-5909,GTPL 5909,MRS-2802,GTPL5909,MRS 2802 |
||
MRS2802 is a P2Y14 receptor agonist, its EC50 value for P2Y14 receptor is 63 nM. | |||
T68827 |
MRS2690
|
||
MRS2690 is a potent P2Y14 receptor agonist (EC50 = 49 nM) that displays 7-fold higher potency than UDP-glucose. | |||
T23023 |
MRS2500 tetraammonium
MRS 2500 tetraammonium salt |
Others | Others |
Highly potent and selective antagonist of the platelet P2Y1 receptor |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T33508 |
MRS928
3,5,7-Trimethoxyflavone,MRS-928,MRS 928 |
Others | Others |
MRS928 (3,5,7-Trimethoxyflavone) 是一种生物活性化学品。它具有作为植物代谢物的作用。它来自高良姜素。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-00528 |
CD204/MSR1 Protein, Mouse, Recombinant (His)
MSR,Scara1,macrophage scavenger receptor 1,MSR-A,Scvr,MR... |
Mouse | HEK293 Cells |
CD204/MSR1 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 32 kDa and the accession number is AAH03814.1. | |||
TMPH-02503 |
DEFA1 Protein, Mouse, Recombinant (GST & His)
HP-1,HNP-1,Defensin, alpha 1,DEFA1,DEFA2,MRS,Neutro... |
Mouse | E. coli |
Probably contributes to the antimicrobial barrier function of the small bowel mucosa. Has antibacterial activity against attenuated mutants of S.typhimurium. DEFA1 Protein, Mouse, Recombinant (GST & His) is expressed in E. coli expression system with N-6xHis-GST tag. The predicted molecular weight is 34.1 kDa and the accession number is P11477. | |||
TMPH-01772 |
DEFA1 Protein, Human, Recombinant (GST)
MRS,HP1,HP-1,DEFA1,DEF1,Defensin, alpha 1,Neutrophi... |
Human | E. coli |
Defensin 1 and defensin 2 have antibacterial, fungicide and antiviral activities. Has antimicrobial activity against Gram-negative and Gram-positive bacteria. Defensins are thought to kill microbes by permeabilizing their plasma membrane. DEFA1 Protein, Human, Recombinant (GST) is expressed in E. coli expression system with N-GST tag. The predicted molecular weight is 37.2 kDa and the accession number is P59665. | |||
TMPH-03529 |
Chemotaxis inhibitory Protein, S. aureus (strain MRSA252), Recombinant (His)
CHIPS,Chemotaxis inhibitory protein,chp |
Staphylococcus aureus | P. pastoris (Yeast) |
Involved in countering the first line of host defense mechanisms. Specifically inhibits the response of human neutrophils and monocytes to complement anaphylatoxin C5a and formylated peptides, like N-formyl-methionyl-leucyl-phenylalanine (fMLP). Acts by binding directly to the C5a receptor (C5aR) and formylated peptide receptor (FPR), thereby blocking the C5a- and fMLP-induced calcium responses. Prevents phagocytosis of the bacterium. Chemotaxis inhibitory Protein, S. aureus (strain MRSA252), Re... | |||
TMPH-03532 |
ClfB Protein, S. aureus (strain MRSA252), Recombinant (His & SUMO)
Clumping factor B,clfB,Fibrinogen receptor B,Fibrinogen-bind... |
Staphylococcus aureus | E. coli |
Cell surface-associated protein implicated in virulence by promoting bacterial attachment to both alpha- and beta-chains of human fibrinogen and inducing the formation of bacterial clumps. ClfB Protein, S. aureus (strain MRSA252), Recombinant (His & SUMO) is expressed in E. coli expression system with N-6xHis-SUMO tag. The predicted molecular weight is 69.8 kDa and the accession number is Q6GDH2. |